Genetic Toxicology Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F, Segmented by Component (Reagents & Consumables, Assays, Services), By Type (In Vitro v/s In Vivo), By Application (Pharmaceutical & Biotechnology, Cosmetics, Food, Others), By Region

  • Industry : Healthcare
  • Pages : NA
  • Published Date : NA
Customization Enquiry

Buy Now

Summary

Report Description

Global genetic toxicology testing market is anticipated to witness an impressive growth during the forecast period. This can be ascribed to the growing focus on drug discovery, and development of new treatment or therapies for various diseases. Additionally, growing use of personalized medicine in various in vitro procedures is expected to drive the market growth in the coming years. Besides, the increasing demand for humanized animal models for conducting different research is expected to create lucrative opportunities for the market growth in the coming years. Additionally, the presence of numerous players operating in the market working in the genetic toxicology testing industry is expected to drive the market growth in the forecast period. Additionally, growing geriatric population across the globe which is susceptible to different kinds of chronic diseases is further expected to increase the demand for genetic toxicology testing, thereby fuelling the market growth through 2028. Besides, growing application of genetic toxicology testing across various end user industries including food, cosmetics, pharmaceutical, among others is expected to support the genetic toxicology testing market during the forecast period. The increasing drug development and discovery activities is further supporting the market growth. Also, rising popularity of pharmacogenomics is expected to create lucrative opportunities for the market growth in the coming years. Furthermore, increasing adoption of advanced technology in emerging countries are further expected to increase the demand for genetic toxicology testing, thereby supporting the market growth. In 2015, 42 percent of all drugs, in development, had the potential to be personalized medicines, while 73 percent of oncology drugs had the potential to be personalized medicines in the United States. There is currently a lack of standardization in the genetic toxicology field, which makes it difficult to compare data and results across different studies and laboratories. This can lead to inconsistencies and errors in data interpretation, which can impact the reliability of genetic toxicology testing. Genetic toxicology testing can be expensive, particularly when using advanced technologies and methods. This can make it difficult for researchers and companies with limited resources to conduct large-scale studies or product development programs. The genetic toxicology market is heavily regulated, with strict guidelines and regulations in place to ensure the safety and efficacy of new products and technologies. Obtaining regulatory approval can be a lengthy and costly process, which can impact the ability of companies to bring new products to market. Genetic toxicology testing raises ethical concerns, particularly when it comes to the use of animal models and the potential for unintended consequences. There is a need to balance the benefits of genetic toxicology testing with the ethical considerations and potential risks associated with these tests.

Growing Demand for Personalized Medicine

Increasing demand for personalized medicine for the treatment of different diseases is expected to propel the market growth in the forecast period. The advancement of molecular medicine has resulted in the novel concept of pharmacogenomics where personalized medicine can provide better medication selection and targeted therapy. Additionally, it helps to reduce the side effects along with improve patient experience. Increasing research and development investments in the early stages of drug development are also expected to increase the utilization of in-vivo toxicology techniques before the drug reaches the high-cost clinical stages. This increases the demand for genetic toxicology services. For many genetically modified food, drugs, chemicals, pesticides, and vaccines, several countries' government requires toxicology testing as a pre-requisite for imports and exports. Between 2006 and 2010, investment in personalized medicine in the United States grew by 73 percent, as per reports.

Increasing demand for genetic toxicology testing

With the increasing awareness about the potential health hazards associated with exposure to genotoxic agents, there is a growing demand for genetic toxicology testing. This is driving the growth of the global genetic toxicology testing market. Genetic toxicology testing can be used to identify substances that have the potential to cause genetic damage and mutations. This information can help regulators to set limits on exposure to these substances in order to minimize the risk of disease. Genetic toxicology testing is also used to assess the safety of pharmaceuticals. Before a new drug can be approved for use, it must undergo extensive safety testing, including genetic toxicology testing, to ensure that it does not cause mutations or other genetic damage that could lead to disease. Genetic toxicology testing can be used to evaluate the potential genotoxicity of environmental hazards such as air and water pollution, pesticides, and industrial chemicals. This information can be used to develop regulations to limit exposure to these hazards and protect public health. Genetic toxicology testing can also be used in the development of new treatments for diseases such as cancer. By identifying genotoxic substances that are specific to cancer cells, researchers can develop targeted therapies that minimize damage to healthy cells and maximize the effectiveness of the treatment.

Rising incidence of cancer

The increasing prevalence of cancer is also driving the growth of the genetic toxicology testing market. Genetic toxicology testing is used to assess the potential carcinogenicity of chemicals, drugs, and other substances, and is therefore a key tool in the fight against cancer. As the global population ages, the incidence of cancer is increasing. Cancer is more common in older adults, and as the proportion of older people in the population grows, so too does the incidence of cancer. Exposure to environmental factors such as air pollution, water pollution, and hazardous chemicals can increase the risk of cancer. As industrialization and urbanization continue to spread around the world, more people are being exposed to these environmental hazards. Lifestyle factors such as smoking, alcohol consumption, poor diet, lack of exercise, and obesity have been linked to an increased risk of cancer. As more people adopt unhealthy lifestyles, the incidence of cancer is increasing. Certain genetic mutations can increase the risk of developing cancer. While these mutations are relatively rare, they can be passed down from generation to generation and can increase the overall incidence of cancer. Improved diagnostic tools and screening programs have led to earlier detection of cancer, which can make it appear as though the incidence of cancer is increasing even if the actual number of cases remains the same. In 2020, there were an estimated 19.3 million new cancer cases and 10 million cancer deaths worldwide.

Increasing R&D activities

Increasing the approval of various drugs candidates and increasing acceptance of compounds in the preclinical stages is expected to grow the genetic toxicology testing market over the years. To achieve the main goal of drug discovery, intensive research and development activities are conducted in the early stages of drug development. This, in turn, enhances the demand for genetic toxicology services in the forecast period. Different companies operating in food, cosmetic, healthcare sector is adopting genetic toxicology leading to a rise in demand for genetic toxicology services, thereby fuelling the growth of the market. Federal government spending for health care grew 36.0% in 2020, significantly faster than the 5.9% growth in 2019. There is a growing focus on research and development activities in the field of genetic toxicology testing, which is driving the growth of the market. This is leading to the development of new and innovative genetic toxicology testing methods, which are expected to further drive the growth of the market in the coming years.

Recent Development

  • In 2021, Trevigen, a division of Bio-Techne Corporation, launched a new product called CometChip, which is a high-throughput comet assay that allows researchers to evaluate DNA damage in hundreds of samples simultaneously. The assay is designed to help researchers identify potential genotoxic agents and evaluate the effectiveness of DNA damage repair mechanisms.
  • In 2020, Indivumed GmbH launched a new product called BlueScreen HC, which is a high-throughput genotoxicity screening assay that uses genetically engineered bacterial cells to detect DNA damage. The assay is designed to help researchers evaluate the safety of drugs, chemicals, and other compounds.
  • In 2019, Gentronix Limited launched a new product called ToxiQuant®-Fluo, which is a high-throughput assay that measures DNA damage and repair in human cells. The assay is designed to help researchers evaluate the genotoxicity of compounds and potential cancer-causing agents.


Download Free Sample Report

Market Segmentation

Global genetic toxicology testing market can be segmented by component, by type, by application and by region. Based on component, the market can be segmented into Reagents & Consumables, Assays, Services. Based on type, the market can be divided into In Vitro and In Vivo. Based on application, the market can be grouped into Pharmaceutical & Biotechnology, Cosmetics, Food, Others. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, United States dominated the global genetic toxicology testing market, on account of growing demand for personalized medicine and increasing investment in the healthcare industry in the country.

Market Players

Thermo Fisher Scientific, Inc., Eurofins Scientific SE, Jubilant Life Sciences Limited, Syngene International Limited, Gentronix Ltd., Inotiv Inc., Charles River Laboratories International, Inc., Merck KGaA, Toxikon Corporation, Gentronix Limited are some of the leading players operating in the Global Genetic Toxicology Testing Market.

Recent Developments

  • Inotiv, Inc. in July 2022 announced that it would be continuing to expand its capacity to conduct genetic toxicology studies for in vitro cytogenetics and bacterial assays. This will help in supporting the development of novel therapeutics.
  • In November 2021, United Kingdom based contract research organization, Gentronix announced that they have raised around USD 743,000(Euro 700) for the expansion of its lab facilities by enhancing its capacity for ocular, genetic, and skin toxicology testing.

Attribute

Details

Base Year

2022

Historic Data

2018 – 2021

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

By Component

By Type

By Application

By Region

Regional scope

North America; Europe; Asia Pacific; South America; Middle East & Africa

Country scope

United States; Canada; Mexico; France; Germany; United Kingdom; Italy; Spain; China; India; Japan; South Korea; Australia; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE; Egypt; Turkey

Key companies profiled

Thermo Fisher Scientific, Inc., Eurofins Scientific SE, Jubilant Life Sciences Limited, Syngene International Limited, Gentronix Ltd., Inotiv Inc., Charles River Laboratories International, Inc., Merck KGaA, Toxikon Corporation, Gentronix Limited

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Report Scope:

In this report, global genetic toxicology testing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Genetic Toxicology TestingMarket, By Component:

o   Reagents & Consumables

o   Assays

o   Services

  • Genetic Toxicology Testing Market, By Type:

o    In Vitro

o    In Vivo

  • Genetic Toxicology TestingMarket, By Application:

o    Pharmaceutical & Biotechnology

o    Cosmetics

o    Food

o    Others

  • Genetic Toxicology Testing Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • United Kingdom
      • Italy
      • Spain
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Australia
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
      • Egypt
      • Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Genetic Toxicology Testing Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Genetic Toxicology TestingMarket is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.     Markets Covered

1.2.2.     Years Considered for Study

1.2.3.     Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Global Genetic Toxicology Testing Market Outlook

5.1.  Market Size & Forecast

5.1.1.     By Value

5.2.  Market Share & Forecast

5.2.1.     By Component (Reagents & Consumables, Assays, Services)

5.2.2.     By Type (In Vitro v/s In Vivo)

5.2.3.     By Application (Pharmaceutical & Biotechnology, Cosmetics, Food, Others)

5.2.4.     By Region

5.2.5.     By Company (2022)

5.3.  Market Map

5.3.1.     By Component

5.3.2.     By Type

5.3.3.     By Application

5.3.4.     By Region

6.    North America Genetic Toxicology Testing Market Outlook

6.1.  Market Size & Forecast          

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Component

6.2.2.     By Type

6.2.3.     By Application

6.2.4.     By Country

6.3.  North America: Country Analysis

6.3.1.     United States Genetic Toxicology Testing Market Outlook

6.3.1.1.         Market Size & Forecast

6.3.1.1.1.             By Value

6.3.1.2.         Market Share & Forecast

6.3.1.2.1.             By Component

6.3.1.2.2.             By Type

6.3.1.2.3.             By Application

6.3.2.     Canada Genetic Toxicology Testing Market Outlook

6.3.2.1.         Market Size & Forecast

6.3.2.1.1.             By Value

6.3.2.2.         Market Share & Forecast

6.3.2.2.1.             By Component

6.3.2.2.2.             By Type

6.3.2.2.3.             By Application

6.3.3.     Mexico Genetic Toxicology Testing Market Outlook

6.3.3.1.         Market Size & Forecast

6.3.3.1.1.             By Value

6.3.3.2.         Market Share & Forecast

6.3.3.2.1.             By Component

6.3.3.2.2.             By Type

6.3.3.2.3.             By Application

7.    Europe Genetic Toxicology Testing Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Component

7.2.2.     By Type

7.2.3.     By Application

7.2.4.     By Country

7.3.  Europe: Country Analysis

7.3.1.     France Genetic Toxicology Testing Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Component

7.3.1.2.2.             By Type

7.3.1.2.3.             By Application

7.3.2.     Germany Genetic Toxicology Testing Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Component

7.3.2.2.2.             By Type

7.3.2.2.3.             By Application

7.3.3.     United Kingdom Genetic Toxicology Testing Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Component

7.3.3.2.2.             By Type

7.3.3.2.3.             By Application

7.3.4.     Italy Genetic Toxicology Testing Market Outlook

7.3.4.1.         Market Size & Forecast

7.3.4.1.1.             By Value

7.3.4.2.         Market Share & Forecast

7.3.4.2.1.             By Component

7.3.4.2.2.             By Type

7.3.4.2.3.             By Application

7.3.5.     Spain Genetic Toxicology Testing Market Outlook

7.3.5.1.         Market Size & Forecast

7.3.5.1.1.             By Value

7.3.5.2.         Market Share & Forecast

7.3.5.2.1.             By Component

7.3.5.2.2.             By Type

7.3.5.2.3.             By Application

8.    Asia-Pacific Genetic Toxicology Testing Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Component

8.2.2.     By Type

8.2.3.     By Application

8.2.4.     By Country

8.3.  Asia-Pacific: Country Analysis

8.3.1.     China Genetic Toxicology Testing Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Component

8.3.1.2.2.             By Type

8.3.1.2.3.             By Application

8.3.2.     India Genetic Toxicology Testing Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Component

8.3.2.2.2.             By Type

8.3.2.2.3.             By Application

8.3.3.     Japan Genetic Toxicology Testing Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Component

8.3.3.2.2.             By Type

8.3.3.2.3.             By Application

8.3.4.     South Korea Genetic Toxicology Testing Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Component

8.3.4.2.2.             By Type

8.3.4.2.3.             By Application

8.3.5.     Australia Genetic Toxicology Testing Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Component

8.3.5.2.2.             By Type

8.3.5.2.3.             By Application

9.    South America Genetic Toxicology Testing Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Component

9.2.2.     By Type

9.2.3.     By Application

9.2.4.     By Country

9.3.  South America: Country Analysis

9.3.1.     Brazil Genetic Toxicology Testing Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Component

9.3.1.2.2.             By Type

9.3.1.2.3.             By Application

9.3.2.     Argentina Genetic Toxicology Testing Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Component

9.3.2.2.2.             By Type

9.3.2.2.3.             By Application

9.3.3.     Colombia Genetic Toxicology Testing Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Component

9.3.3.2.2.             By Type

9.3.3.2.3.             By Application

10.  Middle East and Africa Genetic Toxicology Testing Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Component

10.2.2.  By Type

10.2.3.  By Application

10.2.4.  By Country

10.3.              MEA: Country Analysis

10.3.1.  South Africa Genetic Toxicology Testing Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Component

10.3.1.2.2.           By Type

10.3.1.2.3.           By Application

10.3.2.  Saudi Arabia Genetic Toxicology Testing Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Component

10.3.2.2.2.           By Type

10.3.2.2.3.           By Application

10.3.3.  UAE Genetic Toxicology Testing Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Component

10.3.3.2.2.           By Type

10.3.3.2.3.           By Application

10.3.4.  Egypt Genetic Toxicology Testing Market Outlook

10.3.4.1.      Market Size & Forecast

10.3.4.1.1.           By Value

10.3.4.2.      Market Share & Forecast

10.3.4.2.1.           By Component

10.3.4.2.2.           By Type

10.3.4.2.3.           By Application

10.3.5.  Turkey Genetic Toxicology Testing Market Outlook

10.3.5.1.      Market Size & Forecast

10.3.5.1.1.           By Value

10.3.5.2.      Market Share & Forecast

10.3.5.2.1.           By Component

10.3.5.2.2.           By Type

10.3.5.2.3.           By Application

11.  Market Dynamics

11.1.              Drivers

11.2.              Challenges

12.  Market Trends & Developments

12.1.              Recent Developments

12.2.              Mergers & Acquisitions

12.3.              Product Launches

13.  Competitive Landscape

13.1.              Business Overview

13.2.              Product Offerings

13.3.              Recent Developments

13.4.              Financials (As Reported)

13.5.              Key Personnel

13.6.              SWOT Analysis

13.6.1.  Thermo Fisher Scientific, Inc.

13.6.2.  Eurofins Scientific SE

13.6.3.  Jubilant Life Sciences Limited

13.6.4.  Syngene International Limited

13.6.5.  Gentronix Ltd.

13.6.6.  Inotiv Inc.

13.6.7.  Charles River Laboratories International, Inc.

13.6.8.  Merck KGaA

13.6.9.  Toxikon Corporation

13.6.10.                Gentronix Limited

Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

Increasing demand for personalized medicine along with increasing investments by government organizations are some of the major factors driving the growth of global genetic toxicology testing market.

down-arrow

Thermo Fisher Scientific, Inc., Eurofins Scientific SE, Jubilant Life Sciences Limited, Syngene International Limited, Gentronix Ltd., Inotiv Inc., Charles River Laboratories International, Inc., Merck KGaA, Toxikon Corporation, Gentronix Limited are some of the leading players operating in the Global Genetic Toxicology Testing Market.

down-arrow

The Services segment is expected to dominate the global genetic toxicology testing market during the forecast period.

down-arrow

North America region is expected to hold the largest share in the Global Genetic Toxicology Testing Market.

Related Reports

profile

Sakshi Bajaal

Business Consultant
Press Release

Genetic Toxicology Testing Market to be dominated by Services type through 2028

Jan, 2023

Increasing demand for personalized medicine is expected to drive the growth of global genetic toxicology testing in the forecast period, 2024-2028.

Why Choose Us